CDKN2A and Miyoshi myopathy: Around 40% of newly diagnosed patients with MM displayed hypermethylation at the INK4A promoter, 10–80% at the CDKN2B promoter, and rare incidences of promoter methylation occurred at CDKN2C or members of the Cip/Kip family [174].